Inventor
CORTI DAVIDE
CH54 patents
⚠️ This page may combine multiple inventors who share the name “CORTI DAVIDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HUMABS BIOMED SA
18 patentsUS11390664B2Jul 19, 2022
Antibodies that potently neutralize hepatitis B virus and uses thereof
HUMABS BIOMED SA5 citations84
US10683344B2Jun 16, 2020
Antibodies that potently neutralize hepatitis B virus and uses thereof
HUMABS BIOMED SA6 citations84
US10047145B2Aug 14, 2018
Antibodies that potently neutralize RSV and uses thereof
HUMABS BIOMED SA5 citations84
US11117954B2Sep 14, 2021
Antibodies specifically binding to zika virus epitopes and uses thereof
HUMABS BIOMED SA2 citations73
US10759847B2Sep 1, 2020
Antibodies that potently neutralize RSV and uses thereof
HUMABS BIOMED SA1 citations73
US10329342B2Jun 25, 2019
Antibodies that potently neutralize RSV and uses thereof
HUMABS BIOMED SA3 citations73
US10072071B2Sep 11, 2018
Antibodies that neutralize RSV, MPV and PVM and uses thereof
HUMABS BIOMED SA2 citations73
US12304946B2May 20, 2025
Antibodies that neutralize hepatitis B virus and uses thereof
HUMABS BIOMED SA1 citations64
US9498531B2Nov 22, 2016
Antibodies that neutralize RSV, MPV and PVM and uses thereof
HUMABS BIOMED SA2 citations63
US12037381B2Jul 16, 2024
Antibodies that potently neutralize hepatitis B virus and uses thereof
HUMABS BIOMED SA0 citations62
US11912757B2Feb 27, 2024
Antibodies specifically binding to Zika virus epitopes and uses thereof
HUMABS BIOMED SA0 citations62
US11421020B2Aug 23, 2022
Antibodies that neutralize RSV, MPV and PVM and uses thereof
HUMABS BIOMED SA0 citations62
US11370829B2Jun 28, 2022
Antibodies that potently neutralize RSV and uses thereof
HUMABS BIOMED SA0 citations62
US11730813B2Aug 22, 2023
Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof
HUMABS BIOMED SA0 citations57
US11723977B2Aug 15, 2023
Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof
HUMABS BIOMED SA0 citations57
US11926658B2Mar 12, 2024
Multispecific antibodies specifically binding to Zika virus epitopes
HUMABS BIOMED SA0 citations52
US12297258B2May 13, 2025
Antibodies against Campylobacter species
HUMABS BIOMED SA0 citations50
US10703801B2Jul 7, 2020
Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
HUMABS BIOMED SA0 citations47
MEDIMMUNE LLC
17 patentsUS11174304B2Nov 16, 2021
Neutralizing anti-influenza B antibodies and uses thereof
MEDIMMUNE LLC5 citations83
US10519221B2Dec 31, 2019
Neutralizing anti-influenza B antibodies and uses thereof
MEDIMMUNE LLC8 citations83
US10294292B2May 21, 2019
Neutralizing anti-influenza B antibodies and uses thereof
MEDIMMUNE LLC4 citations83
US10494419B2Dec 3, 2019
Neutralizing anti-influenza A antibodies and uses thereof
MEDIMMUNE LLC9 citations82
US11787853B2Oct 17, 2023
Neutralizing anti-influenza b antibodies and uses thereof
MEDIMMUNE LLC2 citations72
US11059884B2Jul 13, 2021
Antibodies directed against Staphylococcus aureus leukotoxins
MEDIMMUNE LLC4 citations71
US11155606B2Oct 26, 2021
Antibody directed against S. aureus clumping factor a (ClfA)
MEDIMMUNE LLC3 citations69
US11117956B2Sep 14, 2021
Anti-O1 antibodies and uses thereof
MEDIMMUNE LLC3 citations69
US12325740B2Jun 10, 2025
Neutralizing anti-influenza B antibodies and uses thereof
MEDIMMUNE LLC0 citations61
US12492240B2Dec 9, 2025
Neutralizing anti-influenza A antibodies and uses thereof
MEDIMMUNE LLC0 citations60
US11932682B2Mar 19, 2024
Neutralizing anti-influenza A antibodies and uses thereof
MEDIMMUNE LLC0 citations60
US11578119B2Feb 14, 2023
Antibodies directed against Staphylococcus aureus leukotoxins
MEDIMMUNE LLC1 citations60
US11186627B2Nov 30, 2021
Neutralizing anti-influenza A antibodies and uses thereof
MEDIMMUNE LLC0 citations60
US12312397B2May 27, 2025
Anti-O2 antibodies and uses thereof
MEDIMMUNE LLC0 citations59
US12018068B2Jun 25, 2024
Anti-O1 antibodies and uses thereof
MEDIMMUNE LLC0 citations59
US11447542B2Sep 20, 2022
Anti-O2 antibodies and uses thereof
MEDIMMUNE LLC1 citations59
US11970527B2Apr 30, 2024
Antibody directed against S. aureus clumping factor A (ClfA)
MEDIMMUNE LLC0 citations58
US HEALTH
7 patentsUS10420834B2Sep 24, 2019
Recombinant metapneumovirus F proteins and their use
US HEALTH4 citations84
US11078239B2Aug 3, 2021
Prefusion PIV F immunogens and their use
US HEALTH1 citations72
US12435113B2Oct 7, 2025
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US12233124B2Feb 25, 2025
Recombinant metapneumovirus f proteins and their use
US HEALTH0 citations62
US11845778B2Dec 19, 2023
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US11786591B2Oct 17, 2023
Recombinant metapneumovirus F proteins and their use
US HEALTH0 citations62
US11027007B2Jun 8, 2021
Recombinant metapneumovirus F proteins and their use
US HEALTH0 citations62
VIR BIOTECHNOLOGY INC
3 patentsUS11168128B2Nov 9, 2021
Antibodies against SARS-CoV-2 and methods of using the same
VIR BIOTECHNOLOGY INC12 citations81
US11479599B2Oct 25, 2022
Antibodies against SARS-CoV-2 and methods of using the same
VIR BIOTECHNOLOGY INC2 citations68
US12404318B2Sep 2, 2025
Combination HBV therapy
VIR BIOTECHNOLOGY INC1 citations51
INST RES BIOMEDICINE
3 patentsUS11261245B2Mar 1, 2022
Ultra-potent neutralization of GM-CSF by multispecific antibodies and uses thereof
INST RES BIOMEDICINE0 citations58
US11084850B2Aug 10, 2021
Recombinant prefusion RSV F proteins and uses thereof
INST RES BIOMEDICINE0 citations48
US10526404B2Jan 7, 2020
Multispecific anti GM-CSF antibodies
INST RES BIOMEDICINE0 citations48
ABB TECHNOLOGY AG
1 patentBONFANTI ALESSANDRO
1 patentShowing the top 50 of 54 patents by PatentIndex Score.